Literature DB >> 36214985

Effects of Combined Treatment with Compounds Affecting Mitochondria on Physiological Parameters in Old Monkey.

I N Klots1, T E Gvozdik2, O A Shamsutdinova2, E I Mukhametzyanova2, V V Keburiya2, I A Gvaramiya2, D D Karal-Ogly2.   

Abstract

Correction of mitochondrial function is a promising direction for modulating aging processes. The effect of NAD+ (in the form of its precursor nicotinamide mononucleotide, NMN) and antioxidant MitoQ specifically affecting mitochondria was studied on male rhesus monkeys (Macaca mulatta). The first group of animals initially received only NMN, the second group received only MitoQ, and then both groups received both drugs simultaneously. The above treatment did not lead to changes in the body weight and body temperature, hemostasis, and ECG. The use of MitoQ, but not NMN improved some hematological and biochemical parameters, shifting them to the values of young animals. Changes in these parameters depended on animal age, so the use of MitoQ can only be effective until a certain age. Combined use of the two drugs had no clear advantages over MitoQ alone.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  MitoQ; aging; nicotinamide mononucleotide

Mesh:

Substances:

Year:  2022        PMID: 36214985     DOI: 10.1007/s10517-022-05606-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  3 in total

1.  Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Authors:  Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

2.  Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.

Authors:  Matthew J Rossman; Jessica R Santos-Parker; Chelsea A C Steward; Nina Z Bispham; Lauren M Cuevas; Hannah L Rosenberg; Kayla A Woodward; Michel Chonchol; Rachel A Gioscia-Ryan; Michael P Murphy; Douglas R Seals
Journal:  Hypertension       Date:  2018-04-16       Impact factor: 10.190

Review 3.  Mitochondria-Targeted Drugs.

Authors:  Roman A Zinovkin; Andrey A Zamyatnin
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.